Avantor, Inc. AVTR
We take great care to ensure that the data presented and summarized in this overview for Avantor, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AVTR
View all-
Dodge & Cox San Francisco, CA99.1MShares$1.61 Billion1.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA64MShares$1.04 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY44MShares$713 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD41.4MShares$670 Million0.54% of portfolio
-
Barrow Hanley Mewhinney & Strauss LLC Dallas, TX30.5MShares$495 Million2.33% of portfolio
-
State Street Corp Boston, MA23.3MShares$378 Million0.02% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A621MShares$341 Million0.46% of portfolio
-
Janus Henderson Group PLC London, X018.1MShares$294 Million0.2% of portfolio
-
New Mountain Vantage Advisers, L.L.C. New York, NY14MShares$227 Million10.05% of portfolio
-
Geode Capital Management, LLC Boston, MA11.2MShares$182 Million0.02% of portfolio
Latest Institutional Activity in AVTR
Top Purchases
Top Sells
About AVTR
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Insider Transactions at AVTR
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 27
2025
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,033
-2.54%
|
$17,561
$17.0 P/Share
|
Feb 27
2025
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Open market or private sale
|
Direct |
774
-0.89%
|
$13,158
$17.0 P/Share
|
Feb 26
2025
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
4,907
-10.78%
|
$83,419
$17.53 P/Share
|
Feb 26
2025
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Open market or private sale
|
Direct |
3,758
-4.12%
|
$63,886
$17.53 P/Share
|
Feb 25
2025
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
583
-0.64%
|
$9,911
$17.56 P/Share
|
Feb 25
2025
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
505
-1.1%
|
$8,585
$17.56 P/Share
|
Feb 25
2025
|
Michael Stubblefield President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,969
-0.34%
|
$84,473
$17.56 P/Share
|
Feb 25
2025
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
556
-0.65%
|
$9,452
$17.56 P/Share
|
Feb 25
2025
|
Brittany Hankamer EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
369
-0.74%
|
$6,273
$17.56 P/Share
|
Feb 24
2025
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-2.32%
|
$37,077
$17.47 P/Share
|
Feb 24
2025
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
439
-0.95%
|
$7,463
$17.47 P/Share
|
Feb 24
2025
|
Michael Stubblefield President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,800
-0.47%
|
$115,600
$17.47 P/Share
|
Feb 24
2025
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
750
-0.88%
|
$12,750
$17.47 P/Share
|
Feb 24
2025
|
Brittany Hankamer EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
437
-0.87%
|
$7,429
$17.47 P/Share
|
Feb 23
2025
|
Christophe Couturier EVP, AMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
1,506
-1.73%
|
$25,602
$17.3 P/Share
|
Feb 23
2025
|
James Bramwell EVP Sales, Customer Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
3,443
-3.54%
|
$58,531
$17.3 P/Share
|
Feb 23
2025
|
Michael Stubblefield President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,674
-1.0%
|
$249,458
$17.3 P/Share
|
Feb 23
2025
|
Claudius Sokenu EVP, Chief Legal & Compliance |
SELL
Payment of exercise price or tax liability
|
Direct |
2,318
-3.84%
|
$39,406
$17.3 P/Share
|
Feb 23
2025
|
Brittany Hankamer EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,537
-2.96%
|
$26,129
$17.3 P/Share
|
Feb 23
2025
|
Steven W Eck SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,956
-4.04%
|
$33,252
$17.3 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 444K shares |
---|
Payment of exercise price or tax liability | 63K shares |
---|---|
Open market or private sale | 24.1K shares |